Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) with central nervous system activity. Its structure supports the creation of compounds with enhanced metabolic stability and bioavailability due to the trifluoromethyl group. Commonly employed in the preparation of antipsychotics, antidepressants, and other neurologically targeted drugs. The piperazine ring facilitates binding to various biological receptors, making this compound valuable in medicinal chemistry for drug design and optimization. Also utilized in research settings for generating novel analogs in structure-activity relationship (SAR) studies.